Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

- PMLiVE

Apellis jumps as pegcetacoplan tops Alexion’s Soliris in PNH trial

Shares shot up more than 50% in wake of announcement

- PMLiVE

New hires at FibroGen, Saniona and Turbine

The latest movers in pharma

- PMLiVE

imc group bolsters HR & talent division

Anushka Bakshi and Parissa Kamal join the imc team

- PMLiVE

Galen completes acquisition of healthcare company POA Pharma

Takeover expands Galen's global reach and product portfolio

- PMLiVE

Novartis picks up inclisiran after completion of MedCo acquisition

If approved could become blockbuster cholesterol treatment

- PMLiVE

Keytruda doesn’t extend survival in small cell lung cancer

Unlikely to extend use into the first-line setting

- PMLiVE

EU, US biotechs merge to create fibrosis, cancer player

New company will be headquartered in Copenhagen, Denmark

- PMLiVE

Merck KGaA, Pfizer’s Bavencio improves survival in bladder cancer

Confirmatory trial strengthens claim in therapy area

- PMLiVE

Merck strengthens KRAS stake with Taiho and Astex partnership

Partner companies could gain $2.5bn in milestone payments

- PMLiVE

Green Valley’s algae-based Alzheimer’s drug to undergo global clinical trials

Gained conditional approval in China in November

AstraZeneca AZ

AstraZeneca’s heart failure drug Farxiga scores FDA priority review

Approval in HFrEF would significantly expand drug's reach

- PMLiVE

NICE rejects Akcea’s rare inherited disorder drug Waylivra

Draft guidance deems drug too costly for NHS use

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links